C
WST icon

Cerebellum’s West Pharmaceutical WST Stock Holding History

Cerebellum’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$562K Buy
3,736
+676
+22% +$98.4K 0.3% 86
2019
Q3 		$434K Buy
3,060
+121
+4% +$16.7K 0.28% 215
2019
Q2 		$368K Sell
2,939
-249
-8% -$29.4K 0.3% 13
2019
Q1 		$351K Buy
+3,188
New +$332K 0.3% 3

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Cerebellum's WST Position: Q4 2019 in Review

Cerebellum increased its West Pharmaceutical (WST) stake by 22% in Q4 2019, buying an estimated $98.4K and bringing the position to 3,736 shares worth $562K. The position accounts for 0.3% of the portfolio, ranked #86.

Cerebellum first reported a position in WST in Q1 2019 and has held it in 4 quarters since. 445 funds tracked by Wall St. Rank hold WST as of Q4 2019.

  • Cerebellum held 3,736 shares of West Pharmaceutical worth $562K as of Q4 2019.
  • Cerebellum bought 676 West Pharmaceutical shares in Q4 2019, an estimated $98.4K.
  • West Pharmaceutical made up 0.3% of Cerebellum's portfolio in Q4 2019, its #86 holding.
  • Cerebellum first reported a position in West Pharmaceutical in Q1 2019 and has held it in 4 quarters since.
  • 445 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2019.

Based on Cerebellum's 13F filing for Q4 2019, filed 16 Jan 2020.